roubaixtuesday
Well-Known Member
- Joined
- 14 Dec 2019
- Messages
- 4,352
- Team supported
- City
At the same time - see edit above.
You would have hoped this is on purpose and sees some degree of cooperation.
Ah, thanks, hadn't twigged that.
I hope you're right and perhaps this is the start of a more cooperative approach between UK and our near neighbours (though to be fair, the EMA and the MHRA have been very consistent throughout).
I would guess three potential outcomes
(1) No problem, carry on
(2) Issue with section of population (eg females under 50) - restrict use
(3) Small issue, carry on but with advised monitoring and treatment regimen to minimise consequences.
I would guess (2), (3) or both. We will see. I do hope it's consistent - I think the uncertainty and inconsistency between countries is as damaging as the issue itself.